ConductScience.org, home

Paper6138058

Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.

O'Callaghan WG and 4 others. Br J Clin Pharmacol, 1983. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients. Papers, record 6138058. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6138058

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2019-05-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Callaghan WGW G
2Laher MSM S
3McGarry KK
4O'Brien EE
5O'Malley KK

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
AtenololMajor topic
HypertensionMajor topic
PropanolaminesMajor topic
Renal CirculationMajor topic
Aged
Blood Pressure
Female
Glomerular Filtration Rate
Heart Rate
Humans
Male
Middle Aged
Nadolol

Source PubMed

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,902,175Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow.J Pharmacol Exp Ther1966https://conductscience.org/library/papers/5902175PubMed
25,781,346[Comparative study of the influence of beta-adrenergic stimulants and adrenergic blocking drugs on renal function in normal humans].Minerva Med1969https://conductscience.org/library/papers/5781346PubMed
35,783,162Effect of norepinephrine, isoproterenol, and adrenergic blockers upon the intrarenal distribution of blood flow.Can J Physiol Pharmacol1969https://conductscience.org/library/papers/5783162PubMed
45,057,578A computerized cummulative integral method for the precise measurement of the glomerular filtration rate. 1.Proc Soc Exp Biol Med1972https://conductscience.org/library/papers/5057578PubMed
54,198,769Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.Clin Sci1973https://conductscience.org/library/papers/4198769PubMed
64,151,244Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).Int J Clin Pharmacol1974https://conductscience.org/library/papers/4151244PubMed
7242,209Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.Am J Cardiol1975https://conductscience.org/library/papers/242209PubMed
8963,837beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.Circ Res1976https://conductscience.org/library/papers/963837PubMed
9885,665Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function.Int J Clin Pharmacol Biopharm1977https://conductscience.org/library/papers/885665PubMed
10337,267Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.Postgrad Med J1977https://conductscience.org/library/papers/337267PubMed
11928,260Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity.Postgrad Med J1977https://conductscience.org/library/papers/928260PubMed
12367,412Methods for the assessment of the effects of drugs on renal blood flow.Br J Clin Pharmacol1979https://conductscience.org/library/papers/367412PubMed
13433,946The long-term effect of propranolol therapy on renal function.Am J Med1979https://conductscience.org/library/papers/433946PubMed
14221,809Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.N Engl J Med1979https://conductscience.org/library/papers/221809PubMed
1537,877beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.Br J Clin Pharmacol1979https://conductscience.org/library/papers/37877PubMed
166,103,509Drug therapy: Management of hypertension in the elderly.N Engl J Med1980https://conductscience.org/library/papers/6103509PubMed
176,993,914Hypertension in the elderly.Mod Concepts Cardiovasc Dis1980https://conductscience.org/library/papers/6993914PubMed
186,107,151Renal function in patients with essential hypertension receiving nadolol.Br Med J1980https://conductscience.org/library/papers/6107151PubMed
197,110,207Redistribution of cardiac output to the kidneys during oral nadolol administration.N Engl J Med1982https://conductscience.org/library/papers/7110207PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
27,524,972How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.Front Physiol2016https://conductscience.org/library/papers/27524972PubMed
3,908,126Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3908126PubMed
3,540,917The treatment of hypertension in the elderly.Postgrad Med J1986https://conductscience.org/library/papers/3540917PubMed
2,864,052Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2864052PubMed
2,864,051Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2864051PubMed
1,720,383Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.Drugs1991https://conductscience.org/library/papers/1720383PubMed
1,349,496The effect of celiprolol on glomerular filtration rate and renal blood flow in patients with chronic renal impairment and healthy volunteers.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1349496PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6138058

GET https://conductscience.org/api/papers/v1/6138058/authors